BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/26/2020 2:31:16 PM | Browse: 1054 | Download: 2384
 |
Received |
|
2020-02-24 09:37 |
 |
Peer-Review Started |
|
2020-02-24 09:38 |
 |
First Decision by Editorial Office Director |
|
2020-03-28 12:54 |
 |
Return for Revision |
|
2020-03-28 12:54 |
 |
Revised |
|
2020-04-03 14:44 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2020-04-20 07:01 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2020-04-23 21:58 |
 |
Articles in Press |
|
2020-04-23 21:58 |
 |
Edit the Manuscript by Language Editor |
|
2020-04-29 01:16 |
 |
Typeset the Manuscript |
|
2020-05-25 05:39 |
 |
Publish the Manuscript Online |
|
2020-05-26 14:31 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Obstetrics & Gynecology |
| Manuscript Type |
Basic Study |
| Article Title |
Safety of menstrual blood-derived stromal cell transplantation in treatment of intrauterine adhesion
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Qi-Yuan Chang, Si-Wen Zhang, Ping-Ping Li, Zheng-Wei Yuan and Ji-Chun Tan |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Key Research and Development Program |
2018YFC1002105 |
| Key Research and Development Program of Liaoning Province |
2018020222 |
| Major Special Construction Plan for Discipline Construction Project of China Medical University |
3110118033 |
|
| Corresponding Author |
Ji-Chun Tan, PhD, Doctor, Doctor, Professor, Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, No. 39 Huaxiang Road, Tiexi District, Shenyang 110022, Liaoning Province, China. tjczjh@163.com |
| Key Words |
Menstrual blood-derived stromal cells; Endometrial treatment; Intrauterine adhesion; Stem cell transplantation; Biosafety; Toxicity |
| Core Tip |
Menstrual-derived stromal stem cells (MenSCs) with high proliferative capacity and self-renewal ability have a powerful therapeutic effect in patients with severe intrauterine adhesion. However, safety assessment of MenSCs transplantation is an essential for its further application. Here, we evaluate the short-, medium-, and long-term biosafety of MenSCs via intrauterine transplantation in intrauterine adhesion rat model, with a special focus on toxicity and tumorigenicity. There was no acute, sub-chronic or chronic poisoning, infection, tumor and endometriosis in the rat with intrauterine adhesions after MenSCs transplantation, highlighting that intrauterine transplantation of MenSCs is safe for endometrial treatment. |
| Publish Date |
2020-05-26 14:31 |
| Citation |
Chang QY, Zhang SW, Li PP, Yuan ZW, Tan JC. Safety of menstrual blood-derived stromal cell transplantation in treatment of intrauterine adhesion. World J Stem Cells 2020; 12(5): 368-380 |
| URL |
https://www.wjgnet.com/1948-0210/full/v12/i5/368.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v12.i5.368 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.